Compound Summary
Compound Information
17374-26-4
Compound Name: | 17374-26-4 |
Compound CID: | 1694 |
Synonyms: | 17374-26-4 4,5,6,7-tetrabromobenzotriazole TBB 4,5,6,7-Tetrabromo-1H-benzotriazole TBBt More... |
Iupac Name: | 4,5,6,7-tetrabromo-2H-benzotriazole |
InChI: | InChI=1S/C6HBr4N3/c7-1-2(8)4(10)6-5(3(1)9)11-13-12-6/h(H,11,12,13) |
InChIKey: | OMZYUVOATZSGJY-UHFFFAOYSA-N |
Canonical Smiles: | C1(=C(C2=NNN=C2C(=C1Br)Br)Br)Br |
Isomeric Smiles: | C1(=C(C2=NNN=C2C(=C1Br)Br)Br)Br |
Molecular Weight: | 434.71 |
Molecular Formula: | C6HBr4N3 |
Compound Structure
2D Structure:
3D Structure:
Computed Properties
17374-26-4
Molecular Weight: | 434.71 |
Molecular Formula: | C6HBr4N3 |
Hydrogen Bond Donor Count: | 1 |
Hydrogen Bond Acceptor Count: | 2 |
Rotatable Bond Count: | 0 |
Heavy Atom Count: | 13 |
Complexity: | 184 |
Synonyms
17374-26-4
| 17374-26-4 | 17374-26-4 |
|---|---|
17374-26-4 |
4,5,6,7-tetrabromobenzotriazole |
TBB |
4,5,6,7-Tetrabromo-1H-benzotriazole |
TBBt |
4,5,6,7-tetrabromo-2H-benzotriazole |
4,5,6,7-Tetrabromo-1H-benzod1,2,3triazole |
TETRABROMO-2-BENZOTRIAZOLE |
4,5,6,7-Tetrabromo-2-azabenzimidazole |
Casein Kinase II Inhibitor I |
NSC 231634 |
CHEMBL177820 |
MFCD06411399 |
NSC231634 |
TBB;TBBT |
1p5e |
C6HBr4N3 |
InSolution™ Casein Kinase II Inhibitor I |
SCHEMBL263343 |
GTPL9372 |
STO170 |
SCHEMBL16463781 |
BDBM11323 |
AOB1747 |
DTXSID20274322 |
BDBM420315 |
HMS2043P01 |
HMS3229D01 |
HMS3262L12 |
HMS3268H06 |
HMS3413A16 |
HMS3677A16 |
BCP04100 |
ZINC3870968 |
TBB (NSC 231634) |
TBB, >=98% (HPLC), solid |
Tox21_500935 |
4086AH |
HSCI1_000172 |
s5265 |
AKOS015951304 |
AKOS026750603 |
CCG-222239 |
CS-1079 |
DB04462 |
LP00935 |
NSC-231634 |
SDCCGSBI-0207141.P002 |
NCGC00092352-01 |
NCGC00092352-02 |
NCGC00092352-03 |
NCGC00092352-04 |
NCGC00261620-01 |
1H-Benzoriazole, 4,5,6,7-tetrahydro- |
1H-Benzotriazole, 4,5,6,7-tetrabromo- |
AC-33147 |
AS-16678 |
HY-14394 |
BCP0726000105 |
AB0071659 |
DB-099581 |
FT-0674939 |
T2920 |
TBB;1H-Benzotriazole,4,5,6,7-tetrabromo- |
4,5,6,7-tetrabromo-1h-1,2,3-benzotriazole |
K00040 |
177518-EP2280011A1 |
1H-1,2,3-benzotriazole, 4,5,6,7-tetrabromo- |
A907699 |
Casein Kinase II Inhibitor I - CAS 17374-26-4 |
J-010940 |
BRD-K97118047-001-01-2 |
BRD-K97118047-001-02-0 |
BRD-K97118047-001-03-8 |
Q27095242 |
NSC-231634|||4,5,6,7-Tetrabromo-2H-benzotriazole |
Experimental Data
17374-26-4
| Species | Dosage | Unit | CG Lifespan(AVG/MED days) | TG Lifespan(AVG/MED days) | Lifespan Change(AVG/MED%) | CG Lifespan(MAX days) | TG Lifespan(MAX days) | Lifespan Change(MAX%) | Significant | Strain | Gender | PubMed | Active Label |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Caenorhabditis elegans | 33 | umol/L | -9 | NS | N2 | 24134630 | Inactive |
Experimental Data Visualization
17374-26-4
Statistics Data
17374-26-4
| Species | Lifespan Change(AVG/MED%) | Lifespan Change(MAX%) | Count Reference | Count Data point |
|---|---|---|---|---|
| Caenorhabditis elegans | -9 | 1 | 1 |
Statistics Data Visualization
17374-26-4
